Results 271 to 280 of about 3,107,227 (309)
Some of the next articles are maybe not open access.
Journal of Chronic Diseases, 1962
The Billary System. By W. Taylor, BSc, PhD. Price, $25. Pp 736, with 291 illustrations. F. A. Davis Co., 1914 Cherry St., Philadelphia, Pa 19013, 1965. By J. Vandenbroucke, J. De Groote, and L. O. Standaert. Price, $22. Pp 391, with 165 figures & 72 tables. Williams & Wilkins Co., 428 E Preston St, Baltimore, Md 21202, 1965.
openaire +1 more source
The Billary System. By W. Taylor, BSc, PhD. Price, $25. Pp 736, with 291 illustrations. F. A. Davis Co., 1914 Cherry St., Philadelphia, Pa 19013, 1965. By J. Vandenbroucke, J. De Groote, and L. O. Standaert. Price, $22. Pp 391, with 165 figures & 72 tables. Williams & Wilkins Co., 428 E Preston St, Baltimore, Md 21202, 1965.
openaire +1 more source
Progress in Parkinson's Disease
New England Journal of Medicine, 1984Over the past few years important advances have taken place in the study of Parkinson's disease.
openaire +2 more sources
Progression in Parkinson's Disease
Cold Spring Harbor Perspectives in MedicineParkinson's disease (PD) is a common neurodegenerative disorder characterized by relentlessly progressive motor and nonmotor clinical features. In this paper, we offer a comprehensive overview of progression in PD, covering the heterogeneous symptomatology crucial for monitoring progression from clinical, pathological, and biomarker perspectives.
Krithi, Irmady, Serge, Przedborski
openaire +2 more sources
2012
Imaging disease progression in MS is far from straightforward. Markers that may be relevant in the prediction of conversion from RRMS to SPMS may not be of such use when trying to anticipate disability. MRI features that best correlate with current disability may change as the disease advances, and the optimal combination of measures may also differ ...
Declan Chard, David Miller
openaire +1 more source
Imaging disease progression in MS is far from straightforward. Markers that may be relevant in the prediction of conversion from RRMS to SPMS may not be of such use when trying to anticipate disability. MRI features that best correlate with current disability may change as the disease advances, and the optimal combination of measures may also differ ...
Declan Chard, David Miller
openaire +1 more source
Capivasertib delays disease progression
Nature Reviews Clinical Oncology, 2023openaire +2 more sources
Monitoring Disease Progression in Parkinson's Disease
The Journal of Clinical Pharmacology, 2001openaire +2 more sources
Inflammatory Breast Cancer: The Disease, the Biology, the Treatment
Ca-A Cancer Journal for Clinicians, 2010Melissa L Bondy +2 more
exaly